Global Choroidal Neovascularization Drug Market Detailed Analysis by Types & Applications with Key Companies Profile

The global Choroidal Neovascularization Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Pune, India - December 7, 2017 /MarketersMedia/ —

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Choroidal Neovascularization Drug in these regions, from 2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Access Report Details at:

Global Choroidal Neovascularization Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Cellphire, Inc.
• Chrysalis BioTherapeutics, Inc.
• Cleveland BioLabs, Inc.
• Cumberland Pharmaceuticals, Inc.
• Diffusion Pharmaceuticals Inc.
• Eli Lilly and Company
• GNI Group Ltd.
• Humanetics Corporation
• INSYS Therapeutics, Inc.
• Meabco A/S
• Neumedicines Inc.
• Onconova Therapeutics, Inc.
• PharmaIN Corporation
• Pluristem Therapeutics Inc.
• ProCertus BioPharm Inc.
• RDD Pharma Ltd.
• RedHill Biopharma Ltd.
• RxBio, Inc.
• Soligenix, Inc.

Purchase this Premium Report at:

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• AVMOC-001
• BB-3
• BBT-007
• DG-3
• Entolimod
• EWA-001
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Choroidal Neovascularization Drug for each application, including
• Clinic
• Hospital
• Others

Inquire about this Report at:

Contact Info:
Name: Shirish Gupta
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 275133

Latest News

Mueller examining Cambridge Analytica, Trump campaign ties

Mar 22, 2018

WASHINGTON — Special counsel Robert Mueller is scrutinizing the connections between President Donald Trump's campaign and the data mining firm Cambridge Analytica, which has come under fierce criticism over reports that it swiped the data of more than 50 million Facebook users to sway elections. Mueller's investigators have asked former campaign officials about the Trump campaign's data operations, particularly about how it collected and utilized voter data in battleground states, according to a person with direct knowledge of the line of inquiry but not authorized to discuss it publicly. The investigators have also asked some of Trump's data team, which...

The Latest: Facebook takes baby steps on privacy

Mar 22, 2018

NEW YORK — The Latest on reports that millions of Facebook users' data was used to target political ads (all times local): 6 p.m. Facebook has opted to take little more than baby steps to address its latest scandal over its users' privacy. From the company's perspective, that makes perfect sense. Stronger safeguards on user data might damage Facebook's core business: using what it knows about you to sell ads that target your interests. Facebook is proposing only narrow countermeasures that address the specifics of the furor over Cambridge Analytica, a political consulting firm that's accused of improperly obtaining data...

Budget bill likely would end Supreme Court email search case

Mar 22, 2018

WASHINGTON — The budget bill before Congress includes an update to federal law that makes clear that authorities with a warrant can obtain emails and other data held by American technology companies but stored on servers overseas. Passage of the Cloud Act probably would end a Supreme Court dispute between Microsoft and the Trump administration over emails the government wants as part of a drug trafficking investigation. U.S. authorities obtained a warrant for the emails, but Microsoft has refused to provide the emails because they are kept on a Microsoft server in Ireland. The Cloud Act has the backing of...

Facebook's Zuckerberg apologizes for 'major breach of trust'

Mar 22, 2018

NEW YORK — Breaking five days of silence, Facebook CEO Mark Zuckerberg apologized for a "major breach of trust," admitted mistakes and outlined steps to protect user data in light of a privacy scandal involving a Trump-connected data-mining firm. "I am really sorry that happened," Zuckerberg said of the scandal involving data mining firm Cambridge Analytica. Facebook has a "responsibility" to protect its users' data, he said in a Wednesday interview on CNN. If it fails, he said, "we don't deserve to have the opportunity to serve people." His mea culpa on cable television came a few hours after he...

The Latest: Zuckerberg says it's time to regulate tech firms

Mar 22, 2018

NEW YORK — The Latest on the alleged use of Facebook data to influence the U.S. presidential election (all times local): 10:20 p.m. Facebook CEO Mark Zuckerberg says he believes it's time to impose more regulations on technology companies as they play an increasingly important role in the world. But he isn't spelling what kind of rules he would support beyond requiring clear disclosure about who is paying for online ads. Zuckerberg told CNN in an interview late Wednesday that it no longer is a question whether Facebook and other large tech companies should be more closely regulated. Instead, he...

Sign up now!